Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH10-02-0111
Issue:2010: 104/3 (Sep) pp. 421–653
Pages:456-463

Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis

A. S. Leroyer (1), F. Anfosso (1), R. Lacroix (1, 2), F. Sabatier (1, 3), S. Simoncini (1), S. M. Njock (1), N. Jourde (1, 4), P. Brunet (1, 4), L. Camoin-Jau (1, 2), J. Sampol (1), F. Dignat-George (1, 2)

(1) Laboratoire de Physiopathologie de l'Endothélium - UMR_S 608 INSERM, Université de la Mediterranée, Marseille, France; (2) Laboratoire d’Hématologie, Hôpital de La Conception, Assistance publique – hôpitaux de Marseille, Marseille, France; (3) Laboratoire de Culture et Thérapie Cellulaire, INSERM CIC-BT 510, Hôpital de la Conception, Assistance publique –hôpitaux de Marseille, Marseille, France; (4) Centre de néphrologie et de transplantation rénale, hôpital de la Conception, Assistance publique – Hôpitaux de Marseille, Marseille, France

Summary

Endothelial microparticles (EMP) are complex vesicular structures that can be shed by activated or apoptotic endothelial cells. EMP are composed of a phospholipid bilayer that exposes transmembrane proteins and receptors and encloses cytosolic components such as enzymes, transcription factors and mRNA derived from their parent cells. Thus, EMP behave as biological conveyors playing a key role in the tuning of vascular homeostasis. This review focuses on the multifaceted roles of EMP, notably in coagulation, inflammation and angiogenesis and also on the mechanisms that trigger their formation. In this context, EMP could compromise vascular homeostasis and then represent key players in the pathogenesis of several inflammatory and thrombotic diseases. Consequently, elucidating their role and their mechanisms of formation will bring new insights into the understanding of endothelial-associated diseases. Moreover, in the future, it can open novel therapeutic perspectives based on the inhibition of EMP release.

Keywords

thrombosis, coagulation, inflammation, endothelium, microparticles, vascular homeostasis, vesiculation

DOI

http://dx.doi.org/10.1160/TH10-02-0111

You may also be interested in...

1.

C. Reinhardt

Hämostaseologie 2007 27 1: 55-58

2.

Paul Wexberg1, Nelli Jordanova2, Christoph Strehblow1, Bonni Syeda1, Brigitte Meyer1, Silvia Charvat1, Gerlinde Zorn1, Daniela Scheinig1, Johann Wojta1, Kurt Huber2, Dietmar Glogar1, Mariann Gyöngyösi

Thrombosis and Haemostasis 2008 99 4: 739-748

http://dx.doi.org/10.1160/TH07-05-0365

3.

Andrew J. Gale, Diana Rozenshteyn

Thrombosis and Haemostasis 2008 99 1: 44-51

http://dx.doi.org/10.1160/TH07-08-0495



Articles

You've 254 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...